The objectives of this study are to demonstrate the feasibility of implementing a deprescribing nudge intervention using pragmatic methods, confirm that outcomes can be feasibly measured and evaluated at scale in a subsequent embedded pragmatic clinical trial (ePCT), and explore representativeness of persons living with dementia and care partners identified.
Alzheimer Disease, Mild Cognitive Impairment, Dementia
The objectives of this study are to demonstrate the feasibility of implementing a deprescribing nudge intervention using pragmatic methods, confirm that outcomes can be feasibly measured and evaluated at scale in a subsequent embedded pragmatic clinical trial (ePCT), and explore representativeness of persons living with dementia and care partners identified.
Deprescribing in Patients Living with Dementia with Caregiver and Provider Nudges
-
Mass General Brigham, Boston, Massachusetts, United States, 02120
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
65 Years to
ALL
No
Brigham and Women's Hospital,
Julie Lauffenburger, PharmD, PhD, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital
2025-07-31